Squadron Capital Management’s Mentari Therapeutics, Inc. Common Stock MTRI Stock Holding History
Bought
Maintained
Sold
Other funds holding MTRI
SFCM
Squadron Capital Management's MTRI Position: Q3 2026 in Review
Squadron Capital Management sold out of Mentari Therapeutics, Inc. Common Stock (MTRI) in Q3 2026, closing a stake of 32,500 shares — an estimated $504K sold.
Squadron Capital Management first reported a position in MTRI in Q2 2026 and held it in 1 quarter. The position peaked at $504K in Q2 2026. 16 funds tracked by Wall St. Rank hold MTRI as of Q3 2026.
- Squadron Capital Management reported no remaining Mentari Therapeutics, Inc. Common Stock position as of Q3 2026 after selling out during the quarter.
- Squadron Capital Management sold 32,500 Mentari Therapeutics, Inc. Common Stock shares in Q3 2026, an estimated $504K.
- Squadron Capital Management first reported a position in Mentari Therapeutics, Inc. Common Stock in Q2 2026 and held it in 1 quarter.
- Squadron Capital Management's Mentari Therapeutics, Inc. Common Stock position peaked at $504K in Q2 2026.
- 16 funds tracked by Wall St. Rank held Mentari Therapeutics, Inc. Common Stock as of Q3 2026.
Based on Squadron Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.